Encompass Health Corporation (NYSE: EHC) Securities Fraud Investigation

On July 15, 2025, The New York Times published an article highlighting safety concerns at several of Encompass Health’s rehabilitation hospitals. Specifically, the article detailed incidents of fatal carbon monoxide poisoning, medication errors, and bed alarm failures, raising questions about the quality of care provided by Encompass Health.

On this news, the price of Encompass Health’s stock fell approximately 10%, from a close of $119.67 on July 14, 2025, to close at $107.28 on July 15, 2025.

If you have any questions or would like to discuss this investigation, please contact Kessler Topaz Meltzer & Check, LLP: Jonathan Naji, Esq. (484) 270-1453 or via e-mail at [email protected].

Complete this form with your transactions in Encompass Health Corporation securities between April 25, 2025 and July 14, 2025.

Click Here to Print PDF of this Form

SUBMIT YOUR INFORMATION

* Denotes required field

Date

# of Shares

Price per Share

Date

Principal Amount

Amount Paid

Series or CUSIP

Date

# of Contracts

Price per Contract

Exercise Price

Expiration Date

Add more

Did you purchase shares of Encompass Health Corporation prior to the Class Period?

YesNo

Are you a current or former employee of Encompass Health Corporation?

YesNo

The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. READ MORE

I agree to the KTMC disclaimer

Yes

I would like to receive new case alerts by email

Yes

Please leave this field empty.